Patents by Inventor Mark Theilmann

Mark Theilmann has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • NUCLEIC ACID SAMPLE ENRICHMENT AND SCREENING METHODS
    Publication number: 20230193247
    Abstract: Described herein are methods for enriching test samples for target nucleic acid molecules for further genetic screening. Methods may comprise isolating nucleic acid from test subjects, preparing nucleic acid libraries wherein the nucleic acid molecules are tagged or barcoded to identify sample of origin, determining fragment size distribution, determining abundance of a target nucleic acid population, calculating numerical offset values to determine amount of libraries to add for fragment size selection, performing fragment size selection, and performing a diagnostic assay on a sample enriched for a target nucleic acid.
    Type: Application
    Filed: May 18, 2021
    Publication date: June 22, 2023
    Applicant: Myriad Women's Health, Inc.
    Inventors: Clement Chu, Mark Theilmann, Noah Welker, Peter Grauman
  • Selective nucleic acid amplification from nucleic acid pools
    Patent number: 9862994
    Abstract: Provided herein are nucleic acids and methods for selectively amplifying in parallel tens of thousands of high quality oligonucleotides without common sequences. The resultant oligonucleotides can be used for a variety of purposes and applications including but not limited to DNA nano structure synthesis.
    Type: Grant
    Filed: February 8, 2013
    Date of Patent: January 9, 2018
    Assignee: Dana-Farber Cancer Institute, Inc.
    Inventors: Thorsten Lars Schmidt, Mark Theilmann, William M. Shih
  • SELECTIVE NUCLEIC ACID AMPLIFICATION FROM NUCLEIC ACID POOLS
    Publication number: 20150024972
    Abstract: Provided herein are nucleic acids and methods for selectively amplifying in parallel tens of thousands of high quality oligonucleotides without common sequences. The resultant oligonucleotides can be used for a variety of purposes and applications including but not limited to DNA nano structure synthesis.
    Type: Application
    Filed: February 8, 2013
    Publication date: January 22, 2015
    Applicant: President and Fellows of Harvard College
    Inventors: Thorsten Lars Schmidt, Mark Theilmann, William M. Shih